Clinical trials
Phase 1/2 Carcinoma, Transitional Cell trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Recruiting | 3 |
| Terminated | 3 |
| Completed | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 2 |
| Alentis Therapeutics AG | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Basilea Pharmaceutica | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| Institut Bergonié | 1 |
| Janssen Research & Development, LLC | 1 |
| Lumara Bio Oncologics GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 14 |
| Urinary Bladder Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Carcinoma, Hepatocellular | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 3 |
| Neoplasm Metastasis | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Biliary Tract Neoplasms | 2 |
| Melanoma | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.